H.W.M. Plokker
Utrecht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by H.W.M. Plokker.
Arteriosclerosis, Thrombosis, and Vascular Biology | 2003
C.J.M. Halkes; H. van Dijk; C. Verseyden; P.P.Th. de Jaegere; H.W.M. Plokker; S. Meijssen; D.W. Erkelens; M. Castro Cabezas
Objective—An increased hepatic flow of free fatty acids (FFAs) is associated with impaired peripheral FFA trapping by malfunctioning of the complement component 3 (C3)/acylation-stimulating protein system and overproduction of VLDL in familial combined hyperlipidemia (FCHL). Postprandial ketone bodies reflect FFA oxidation in the liver, but the postprandial changes in male and female patients separately have not been determined yet. Gender differences in postprandial ketone bodies and C3 changes were investigated in normolipidemic patients and patients with untreated FCHL. Methods and Results—Thirty-two normolipidemic patients (16 female and 16 male) and 19 patients with untreated normolipidemia (9 female and 10 male) underwent an oral fat-loading test. Total and incremental areas under the curves (AUC and dAUC, respectively) after the oral fat load were calculated. Triglyceride AUC was similar between genders in each group. Normolipidemic female subjects showed a higher levels of dAUC-hydroxybutyric acid than male subjects (1.37±0.49 and 0.98±0.43 mmol · h/L). In FCHL, a similar trend was observed in female (1.92±0.38) compared with male (1.55±0.87) subjects. In contrast to normolipidemia, FCHL did not show a postprandial increase in C3, although C3 was higher in FCHL. Conclusions—Women have higher postprandial ketone bodies than men, probably reflecting enhanced postprandial hepatic FFA oxidation. In FCHL, both genders have higher postprandial ketone bodies and therefore higher hepatic FFA delivery. The higher fasting and postprandial C3 levels in FCHL may reflect resistance of the C3/acylation-stimulating protein system to promote peripheral fatty acid trapping.
Atherosclerosis | 2009
A. Alipour; A.J.H.H.M. van Oostrom; J.P.H. van Wijk; C. Verseyden; H.W.M. Plokker; J.W. Jukema; A.J. Rabelink; M. Castro Cabezas
Mannose binding lectin (MBL) is one of the three initiators of complement activation and is therefore closely linked to inflammation. MBL deficiency has been associated with the generation of atherosclerosis. Since atherosclerosis, the complement system and postprandial lipemia are linked to inflammation, we studied postprandial lipoprotein metabolism in MBL deficiency. An observational study was carried out in 107 volunteers (21% MBL deficient). Classical cardiovascular risk factors were not different between subjects with and without MBL deficiency. Oral fat loading tests in 8 MBL deficient and 14 MBL sufficient subjects showed similar postprandial triglyceride, free fatty acid, hydroxybutyric acid and complement component 3 concentrations. MBL deficient subjects had 2.4 times lower postprandial Sf>400 (chylomicron)-apoB48 concentrations, but in contrast a 2-3.5 times increased Sf 60-400 (VLDL1-TG) and Sf 60-400-apoB100 response. MBL activity was inversely related to the postprandial Sf 60-400-TG increase. Despite lower postprandial Sf>400-apoB48 concentrations, MBL deficient subjects show an accumulation of Sf 60-400 lipoproteins.
Atherosclerosis | 2004
A.J.H.H.M. van Oostrom; Ton J. Rabelink; C. Verseyden; T.P. Sijmonsma; H.W.M. Plokker; P.P.Th. de Jaegere; M. Castro Cabezas
Arteriosclerosis, Thrombosis, and Vascular Biology | 2001
C.J.M. Halkes; H. van Dijk; P. De Jaegere; H.W.M. Plokker; Y.J.M. van der Helm; D.W. Erkelens; M. Castro Cabezas
Atherosclerosis | 2006
A.J.H.H.M. van Oostrom; H.W.M. Plokker; B. S. Van Asbeck; Ton J. Rabelink; K. P. M. Van Kessel; E.H.J.M. Jansen; C.D.A. Stehouwer; M. Castro Cabezas
Atherosclerosis | 2005
J.P.H. van Wijk; Rudolf J.A Buirma; A. van Tol; C.J.M. Halkes; P.P.Th. de Jaegere; H.W.M. Plokker; Y.J.M. van der Helm; M. Castro Cabezas
Atherosclerosis | 2003
J.P.H. van Wijk; C.J.M. Halkes; P.P.Th. de Jaegere; H.W.M. Plokker; D.W. Erkelens; M. Castro Cabezas
Circulation | 2007
Arash Alipour; A.J.H.H.M. van Oostrom; J. P. Van Wijk; C. Verseyden; H.W.M. Plokker; J.W. Jukema; A.J. (Ton) Rabelink; M. Castro Cabezas
Atherosclerosis Supplements | 2004
J.P.H. van Wijk; C.J.M. Halkes; P. De Jaegere; H.W.M. Plokker; M. Castro Cabezas
Atherosclerosis Supplements | 2008
Arash Alipour; A.J.H.H.M. van Oostrom; J.P.H. van Wijk; C. Verseyden; H.W.M. Plokker; J.W. Jukema; A.J. (Ton) Rabelink; M. Castro Cabezas